A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Clinical trial NCT04669600 · COMPLETED

Trial details

NCT number: NCT04669600
Sponsor: Bioverativ, a Sanofi company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2021-02-04
Primary completion: 2022-02-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.